Loading...
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
BACKGROUND/AIMS: It remains to be determined whether switching from adefovir (ADV) to tenofovir (TDF) provides better virological outcomes in patients exhibiting suboptimal responses to ADV plus nucleoside analogue (ADV+NA) therapy for NA-resistant chronic hepatitis B (CHB). METHODS: In this prospec...
Na minha lista:
| Udgivet i: | Clin Mol Hepatol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association for the Study of the Liver
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5266340/ https://ncbi.nlm.nih.gov/pubmed/27880997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0037 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|